Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Application of adoptive cell therapy in hepatocellular carcinoma
Dengqiang Wu, Yujie Li
Immunology (2023) Vol. 170, Iss. 4, pp. 453-469
Open Access | Times Cited: 16

Showing 16 citing articles:

Atovaquone enhances antitumor efficacy of TCR-T therapy by augmentation of ROS-induced ferroptosis in hepatocellular carcinoma
Anan Chen, Zhiwu Yu, Na Ma, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 3
Open Access | Times Cited: 8
Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease
Jung A Eom, Jin‐Ju Jeong, Sang Hak Han, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 13
Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances
Xiang Wang, Zijun Yuan, Zhengbo Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Surgical treatment for hepatocellular carcinoma in era of multidisciplinary strategies
Takeshi Takamoto, Y. Mihara, Yujiro Nishioka, et al.
International Journal of Clinical Oncology (2025)
Open Access
Diverse approaches and sources to derive antitumor T cell for liver cancer: a single-cell sequence based research
A. F. Zhang, Jiarui Chen, Airong Yang, et al.
Hepatology International (2025)
Closed Access
Exploration of the role of immune cells and cell therapy in hepatocellular carcinoma
Tao Zhang, Chongyang Ren, Zhanyu Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles
Chou‐Yi Hsu, Mohammed Ahmed Mustafa, Ashwani Kumar, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155266-155266
Closed Access | Times Cited: 3
Organ-on-a-chip for studying immune cell adhesion to liver sinusoidal endothelial cells: the potential for testing immunotherapies and cell therapy trafficking
James I. Kennedy, Scott Davies, Peter W. Hewett, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Global research trends in the tumor microenvironment of hepatocellular carcinoma: insights based on bibliometric analysis
Hongmin Han, Ziyin Zhao, Mingyang He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Comprehensive characterization of Fidgetin on tumor immune microenvironment evaluation and immunotherapy in human hepatocellular carcinoma
Longju Qi, Shiyuan Chen, Zehua Liao, et al.
Aging (2024)
Open Access
Macrophages and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Unraveling Molecular Pathways, Immunometabolic Processes, and Their Significance in Immunotherapy for Hepatocellular Carcinoma (HCC)
Chia‐Sheng Chu, Li‐Ling Wu
IntechOpen eBooks (2024)
Open Access
Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment
Sumit Roy, Vancha Harish, Sharfuddin Mohd, et al.
Advanced Therapeutics (2024)
Closed Access
Constructing a prognostic model for hepatocellular carcinoma based on bioinformatics analysis of inflammation-related genes
Yinglian Li, Yuan Fang, Dongli Li, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Advancements and Challenges in Cancer Immunotherapy
Pubali Dey, M Bhattacharjee, Malaya Ghosh, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 1-32
Closed Access
The role of inflammasomes in hepatocellular carcinoma: Mechanisms and therapeutic insights
Valentina Arrè, Roberto Negro, Gianluigi Giannelli
Annals of Hepatology (2024), pp. 101772-101772
Open Access
Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis
Vincent Chin‐Hung Chen, Shao-Lan Huang, Jingyu Huang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12630-12630
Open Access | Times Cited: 1
Page 1

Scroll to top